🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10123+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10123 recruiting trials

Phase 2RecruitingNCT07417761

Tuvusertib in Astrocytoma With ATRX Mutation

👨‍⚕️ Estela Pineda, M.D.; Ph.D., Medical Oncology, Hospital Clínic de Barcelona📍 10 sites📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT07203755

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

👨‍⚕️ Yanxia Wang, Henan Center for Disease Control and Prevention📍 1 site📅 Started Dec 2025View details ↗
Phase 1, PHASE2RecruitingNCT07135050

Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome

🏥 Mahzi Therapeutics📍 3 sites📅 Started Dec 2025View details ↗
RecruitingNCT07294170

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

🏥 argenx📍 5 sites📅 Started Dec 2025View details ↗
Phase 3RecruitingNCT07285460

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

🏥 Sanofi📍 18 sites📅 Started Dec 2025View details ↗
RecruitingNCT07291141

A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis

👨‍⚕️ Mattias Ekstedt, MD, PhD, Linkoeping University📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07085039

Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

👨‍⚕️ Joshua Brandstadter, MD, PhD, MSc, University of Pennsylvania📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07285044

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

👨‍⚕️ Roxana S. Dronca, MD, Mayo Clinic📍 1 site📅 Started Dec 2025View details ↗
NARecruitingNCT07426848

OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients

🏥 Royal College of Surgeons, Ireland📍 1 site📅 Started Dec 2025View details ↗
NARecruitingNCT06990659

Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

👨‍⚕️ Christophe AUBE, Pr, University Hospital, Angers📍 14 sites📅 Started Dec 2025View details ↗
NAEnrolling by InvitationNCT07228156

Study to Evaluate Xtresse Serum in Individuals With Thinning Hair

👨‍⚕️ Melissa Rayner, MS, Restore Biologics Holdings, Inc dba Xtresse📍 4 sites📅 Started Dec 2025View details ↗
Phase 1, PHASE2RecruitingNCT07218770

A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 4 sites📅 Started Dec 2025View details ↗
Phase 1, PHASE2RecruitingNCT07464132

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Dec 2025View details ↗
Phase 1, PHASE2RecruitingNCT06956690

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

👨‍⚕️ Kevin Heller, Hummingbird Bioscience📍 7 sites📅 Started Dec 2025View details ↗
RecruitingNCT07314164

Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

👨‍⚕️ Ipsen Medical Director, Ipsen📍 28 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07311564

A Study of LAD603 in Adults With Alopecia Areata

👨‍⚕️ Study Director, Almirall, S.A.📍 1 site📅 Started Dec 2025View details ↗
Phase 3RecruitingNCT07185997

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

👨‍⚕️ Morgan Lam, ArriVent BioPharm📍 50 sites📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT07323173

A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

👨‍⚕️ xianmin meng, Shanghai Public Health Clinical Center📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07110038

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

👨‍⚕️ Salah-Eddin Al-Batran, Prof. Dr., Frankfurter Institut für Klinische Krebsforschung IKF GmbH📍 2 sites📅 Started Dec 2025View details ↗
RecruitingNCT07505797

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)

🏥 iSono Health, Inc.📍 1 site📅 Started Dec 2025View details ↗
← PreviousPage 33 of 507Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →